About Predxbio
Predxbio is a company based in Pittsburgh (United States) founded in 2017 by Chakra Chennubhotla. Predxbio has raised $2 million across 8 funding rounds from investors including National Science Foundation and Newlin Investment Company. Predxbio offers products and services including Spatially Intelligent Platform, SpaceIQ Platform, and Whitepaper Solutions. Predxbio operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Pictor Labs, among others.
- Headquarter Pittsburgh, United States
- Founders Chakra Chennubhotla
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Predxbio, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2 M (USD)
in 8 rounds
-
Latest Funding Round
$601.32 K (USD), Series B
Aug 04, 2023
-
Investors
National Science Foundation
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Predxbio
Predxbio offers a comprehensive portfolio of products and services, including Spatially Intelligent Platform, SpaceIQ Platform, and Whitepaper Solutions.
Platform for identifying biomarkers in cancer immunotherapy using AI.
Tool for spatial data analysis in drug discovery and clinical trials.
Resource providing insights on spatial biology for immunotherapy advancements.
Funding Insights of Predxbio
Predxbio has successfully raised a total of $2M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $601.32 thousand completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Predxbio
Predxbio has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include National Science Foundation and Newlin Investment Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A private equity and venture capital investor is operated.
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Predxbio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Predxbio
Investment portfolio details for Predxbio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Predxbio
Detailed financials for Predxbio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Predxbio Comparisons
Peer comparison for Predxbio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Predxbio
Predxbio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Pictor Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
|
| Locked | Locked | Locked |
AI-enabled tools for computational pathology and cancer diagnostics are provided.
|
Detailed competitors of Predxbio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Predxbio
Complete news archive for Predxbio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Predxbio
Predxbio was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Predxbio is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Predxbio is a funded company, having raised a total of $2M across 8 funding rounds to date.
Predxbio was founded in 2017 and is headquartered in Pittsburgh, United States. AI technologies are utilized by the company to support drug discovery and clinical development processes within the biopharma sector. Services are offered to biopharmaceutical firms seeking to accelerate research and development timelines through data-driven approaches. Operations focus on integrating artificial intelligence into therapeutic innovation pipelines.
Predxbio's top competitors include Deciphex, Pictor Labs and PathAI.
Predxbio offers Spatially Intelligent Platform, SpaceIQ Platform, and Whitepaper Solutions.
Predxbio has 2 investors. Key investors include National Science Foundation, and Newlin Investment Company.